Comparative

Human disease

pemphigus vulgaris

MONDO:0008219

Mondo defines it as: “Pemphigus is a group of chronic autoimmune skin diseases characterized by blister formations on the outer layer of the skin and the mucous membranes. Three clinical forms have been characterized, of which pemphigus vulgaris is the most frequent (75%).”

1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.

Animal diseases

By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.

OMIA group Name Found by Species The chain reached Score
1188 Pemphigus OMIA's OMIM numbers 5 Human disease 40.0

Human genes

Each human gene of these disease groups that Open Targets links to this disease.

Open Targets links none of these groups' human genes to this disease.

Drugs tested for this disease

Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.

Drug Acts on Latest stage for this disease
Dexamethasone None of these genes Approved
Dexamethasone Phosphoric Acid None of these genes Approved
Prednisone None of these genes Approved
Efgartigimod Alfa None of these genes Phase 3
Mycophenolate Mofetil None of these genes Phase 3
Ofatumumab None of these genes Phase 3
Rilzabrutinib None of these genes Phase 3
Rituximab None of these genes Phase 3
Triamcinolone Acetonide None of these genes Phase 3
Azathioprine None of these genes Phase 2/3
Aldesleukin None of these genes Phase 2
Dapsone None of these genes Phase 2
Etanercept None of these genes Phase 2
Ianalumab None of these genes Phase 2
Infliximab None of these genes Phase 2
Insulin Glargine None of these genes Phase 2
Insulin Human None of these genes Phase 2
Itx-5061 Free Base None of these genes Phase 2
Methylprednisolone None of these genes Phase 2
Parsaclisib None of these genes Phase 2
Prednisolone None of these genes Phase 2
Orilanolimab None of these genes Phase 1/2
Ab-101 None of these genes Phase 1
Pi-0824 None of these genes Phase 1

The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.